Pediatrics
Unique challenges and complexities of pediatric clinical trials explored.
Pregnant participants in clinical trials
Register today for our webinar on the considerations for including pregnant individuals in clinical trials. Learn about guidance in development by regulatory authorities to establish a framework for pregnancy safety studies.
Pediatrics newsletters
December 2024: Centre for Pediatric Clinical Development Newsletter
Welcome to the Winter edition of the Centre for Pediatric Clinical Development (CPCD) newsletter. Here, we bring you insights from the dynamic world of pediatric clinical research, including noteworthy studies and breakthroughs or advancements in the field.
August 2024: Centre for Pediatric Clinical Development Newsletter
Welcome to Summer edition of the Centre for Pediatric Clinical Development (CPCD) newsletter. This issue has a special focus on maternal foetal medicine research brought to you by our Maternal Foetal Medicines Unit, which is a cross-functional team overseen by the CPCD, ensuring comprehensive insight and expertise in studies involving pregnant and lactating individuals as well as their unborn and newborn babies.
April 2024: Centre for Pediatric Clinical Development Newsletter
Welcome to the Spring edition of the Centre for Pediatric Clinical Development newsletter. Here, we bring you insights from the dynamic world of pediatric clinical research, including noteworthy studies and breakthroughs or advancements in the field, making it easy for you to stay up to date.
December 2023: Centre for Pediatric Clinical Development Newsletter
We are delighted to bring you the most up-to-date information and insights from the dynamic world of pediatric clinical research including noteworthy studies and breakthroughs or advancements in the field, making it easy for you to stay in the loop.
Pediatric Risk Assessment Map
The Pediatric Risk Assessment Map is an interactive, reusable, and shareable tool that helps to identify common risks that exist in clinical trials that include pediatric patients and offers mitigation strategies for consideration.
ICON’s World Children’s Day
World Children’s Day is celebrated as an international coming together to advocate for, promote, and celebrate the rights and welfare of children and create dialogue and action plans to build a better world for children. In this webinar, our speakers will explore ongoing regulatory initiatives that aim to promote diversity and inclusion within pediatric therapeutics development.
The RACE for Children Act
Pediatric cancer is the leading cause of death by disease in the US. The intent of the RACE for Children Act is to get more pediatric oncology drugs in the pipeline.
The utility and benefits of adding adolescents to an adult programme
In this webinar, ICON expert, Dr. Martine Dehlinger-Kremer, shares insights on the utility and benefits of adding adolescents to an adult programme, challenges encountered and provides recommendations to overcome these.
The RACE for Children Act prompts more pediatric clinical trials for oncology drug development
In this on-demand webinar, ICON expert Missy Hansen, presents on the pediatric regulatory requirements and study approaches for the development of new medicines, with a particular focus on oncology drug development.
Reflections on pediatric assent: Have we outgrown this concept?
In this webinar, medical ethicists will discuss what investigators, ethics committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand their trial.
Pediatrics podcasts
Designing successful pediatric clinical trials
Dr Jacqui Whiteway, Senior Director, Centre for Pediatric Clinical Development took part in this ACRO’s Good Clinical Podcast episode (S2: E4 ) 'Pediatric Clinical Trials: Compassion in Action' to discuss how industry can make participation in pediatric clinical trials easier for pediatric patients and their families.
Removing Barriers to Pediatric Clinical Trials
In this on- demand Podcast. Dr Jacqui Whiteway, Senior Director, Centre for Pediatric Clinical Development discusses something very important to her, ‘Removing Barriers to Pediatric Clinical Trials and how creating positive experiences and reducing anxiety for children in clinical trials can benefit the pediatric trial eco system’. Listen to find out more.
Pediatrics media contributions and blogs
-
Blog: Navigating Pediatric Drug Development (PDP) in Canada: A comprehensive guide part 2
In the previous blog of this series, we introduced the pilot PDP initiated by Health Canada including the types of PDP that can be submitted and the content and format of a C-PDP. This blog discusses the review of PDPs by Health Canada, amending agreed-to PDPs and annual reporting requirements.
-
Blog: Navigating Pediatric Drug Development (PDP) in Canada: A comprehensive guide part 1
Health Canada is taking steps to increase data availability to help health care providers by piloting a program for PDPs. In our series we review it & provide guidance.
-
Blog: Celebrating World Children’s Day
To mark World Children's Day we reflect on ICON’s commitment to increase pediatric healthcare access and inclusion by supporting pediatric clinical trials.
-
Blog: Designing clinical trials for a complex disease: Pediatric obesity
Pediatric obesity is a complex disease with multiple factors for sponsors to consider when designing and executing treatment trials.
-
Media article: ACRO Good Clinical Podcast: Paediatric clinical trials: Compassion in action
Jacqui Whiteway participates in this discussion on what makes paediatric clinical trials unique and how the industry can make participation easier for paediatric patients and their families.
-
Media article: Paediatric clinical trials for obesity treatment
In this article, ICON experts Alan Baldridge and Heather Peterson discuss the prevalence of paediatric obesity and assess clinical trials of its treatments.
-
Blog: The impact of pediatric medical trauma in clinical trials
Patient-centric pediatric clinical trials can help mitigate the risk of potentially life-long implications of medical trauma and improve trial outcomes.
-
Media article: Accessibility in rare disease paediatric clinical trials
In this International Pharmaceutical Industry article, ICON experts Kirsten Sherman Cervati and William C. Maier discuss strategies to make clinical trials more accessible for Paediatric patients and their families.
Pediatrics services
ICON is invested in bringing safe, effective, pediatric-tested treatments to children. Explore our pediatric experience and how we can support your study from early engagement all the way to approval.